ASK REDCHAT ANYTHING ABOUT VERU INC.
Veru Inc. (NASDAQ: VERU)
Listen to this Section
$2.30
-0.0500
(
-2.13% )
19.3K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| ENTADFI™ (tadalafil and finasteride)DetailsBenign prostatic hyperplasia (BPH) |
Approved |
| Sabizabulin (Veru-111)DetailsCOVID-19 |
Phase 3 |
| Enobosarm +/- abemaciclibDetailsHER2-expressing cancers, ER+/HER2- breast cancer |
Phase 3 |
| Enobosarm +GLP-1 drugs [ Ozempic® + Wegovy® + Mounjaro®]DetailsObesity |
Phase 2b |
| VERU-100DetailsProstate cancer, Cancer |
Failed |
| Sabizabulin (VERU-111)DetailsCastration-resistant prostate cancer |
Failed |
| Zuclomiphene citrateDetailsHot flashes |
Failed |
| Sabizabulin (VERU-111) + EnobosarmDetailsTriple-negative breast cancer , Cancer |
Failed |
Market Data
|
| Open |
$2.30 |
| Previous Close |
$2.35 |
| Volume |
19.3K |
| Market Cap |
$37.72M |
| Day Range |
$2.30 - $2.41 |
| 52 Week Range |
$2.05 - $7.40 |
| Shares Outstanding |
16.05M |
| Change % |
-2.13% |
| Net Change |
▼ -0.0500 |
| Insider Ownership |
-0.04% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 1990 |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
-1,240,814.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-05-09 |
Sale |
-106000.00 |
Greco Michele |
| 2024-05-09 |
Sale |
-102000.00 |
BARNETTE K GARY |
| 2024-05-09 |
Sale |
-102000.00 |
FISCH HARRY |
| 2024-05-09 |
Sale |
-376000.00 |
STEINER MITCHELL SHUSTER |
| 2023-11-17 |
Sale |
-90000.00 |
Rankowitz Michael L |
| 2023-11-17 |
Sale |
-70000.00 |
Eisenberger Mario |
| 2023-11-17 |
Sale |
-80000.00 |
Lu Lucy |
| 2023-11-17 |
Sale |
-60000.00 |
Hyun Grace |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 8-k |
8K-related |
23 |
Oct 30, 2025 |
| 4 |
Insider transactions |
1 |
Oct 03, 2025 |
| 4 |
Insider transactions |
1 |
Oct 03, 2025 |
| 4 |
Insider transactions |
1 |
Oct 03, 2025 |
| 8-k |
8K-related |
14 |
Sep 26, 2025 |
| 8-k |
8K-related |
13 |
Aug 27, 2025 |
| 8-k |
8K-related |
14 |
Aug 12, 2025 |
| 8-k |
8K-related |
16 |
Aug 12, 2025 |
| 10-q |
Quarterly Reports |
75 |
Aug 12, 2025 |
| 8-k |
8K-related |
13 |
Jul 25, 2025 |